Improved in vitro stability of serum osteocalcin by using a new commercially available antiproteolytic compound

Clinica Chimica Acta

Volumn 281, Issue 1-2, 1999, Pages 47-55

  Baumgrass, Ria ^a   Daenzer, Maren ^a   Felsenberg, Dieter ^b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bone Gla Protein; Osteocalcin; Peptide fragments

Indexed keywords

OSTEOCALCIN; PROTEINASE INHIBITOR;

ARTICLE; HUMAN; IMMUNOASSAY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SERUM; STORAGE;

ADULT; FEMALE; FREEZING; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; OSTEOCALCIN; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 0032997451     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00203-4     Document Type: Article

References (16)

1. Hauschka P.V., Wians F.H. Jr. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec. 224:1989;180-188.
2. Price P.A., Williamson M.K., Lothringer J.W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 256:1981;12760-12766.
3. Lian J.B., Gundberg C.M. Osteocalcin. Biochemical consideration and clinical applications. Clin Orthop Rel Res. 226:1988;267-281.
4. Power M.J., Fottrell P.F. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci. 28:1991;287-335.
5. Rosen C.J., Chestnut C.H., Mallinak N.J.S. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 82:1997;1904-1910.
6. Garnero P., Grimaux M., Seguin P., Delmas P.D. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res. 9:1994;255-264.
7. Banfi G., Daverio R. In vitro stability of osteocalcin. Clin Chem. 40:1994;833-834.
8. Durham B.H., Robinson J., Fraser W.D. Differences in the stability of intact osteocalcin in serum, lithium heparin plasma and EDTA plasma. Ann Clin Biochem. 32:1995;422-423.
9. Diego E.M.D., Guerrero R., la Piedra C. Six osteocalcin assays compared. Clin Chem. 40:1994;2071-2077.
10. Lang M., Seibel M.J., Zipf A., Ziegler R. Einfluss eines neuen Proteolysehemmers auf die Haltbarkeit von Osteocalcin im Serum. Clin Lab. 42:1996;5-10.
11. Instruction Manual for OSCAtest Osteocalcin. Brahms Diagnostika GmbH, 1995.
12. Knapen M.H.J., Eisenwiener H.G., Vermeer C. Osteocalcin detection in aging serum and whole blood: stability of different osteocalcin fractions. Clin Chim Acta. 256:1996;151-164.
13. Gundberg C.M., Weinstein R.S. Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest. 77:1986;1762-1767.
14. Blumsohn A., Hannon R.A., Eastell R. Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem. 41:1995;318-319.
15. Tarallo P., Balland M., Henny J. Effect of long-term storage on human plasma osteocalcin level (Letter). Clin Chim Acta. 208:1992;237-239.
16. Merle B., Delmas P.D. Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone. Bone Miner. 11:1990;237-245.